Building a unified design-make-test-decide approach to drug discovery

This resource explores how integrated digital platforms can improve efficiency and decision-making in modern drug discovery workflows. It highlights the transition from traditional design‑make‑test‑analyze cycles to a more dynamic design‑make‑test‑decide approach, enabling real-time insights across multidisciplinary teams.

The Signals One™ platform brings together molecule design, assay data, analytics, and experiment tracking in a unified environment, helping researchers connect data across workflows and reduce inefficiencies caused by fragmented systems. Discover how by supporting collaboration and providing actionable insights, the approach aims to accelerate candidate selection and improve outcomes in complex therapeutic development.